O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-5.92%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.16B
AUM Growth
+$4.16B
(-14%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
48.04%
Holding
122
New
11
Increased
15
Reduced
22
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$97.6M |
| 2 |
Axsome Therapeutics
AXSM
|
$45.1M |
| 3 |
SION
Sionna Therapeutics, Inc. Common Stock
SION
|
$38.8M |
| 4 |
UnitedHealth
UNH
|
$36.8M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$33.6M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$117M |
| 2 |
Merck
MRK
|
$82.6M |
| 3 |
Biogen
BIIB
|
$77.9M |
| 4 |
Intuitive Surgical
ISRG
|
$54.8M |
| 5 |
Universal Health Services
UHS
|
$48.3M |
Sector Composition
| 1 | Healthcare | 99.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vir Biotechnology
VIR
$765M
| $14.6M | 0.35% |
2,248,249
-970,368
| -30% | -$6.29M |
|
52
Cullinan Oncology
CGEM
$456M
| $14.6M | 0.35% |
1,923,855
-18,700
| -1% | -$142K |
|
53
Immatics
IMTX
$662M
| $13.9M | 0.33% |
3,087,462
| – | – |
|
54
Amgen
AMGN
$153B
| $13.8M | 0.33% |
+44,200
| New | +$13.8M |
|
55
Vera Therapeutics
VERA
$1.47B
| $11.6M | 0.28% |
481,065
-261,507
| -35% | -$6.28M |
|
56
Structure Therapeutics
GPCR
$1.14B
| $11.3M | 0.27% |
652,028
| – | – |
|
57
C4 Therapeutics
CCCC
$182M
| $10.9M | 0.26% |
6,830,300
+2,452,400
| +56% | +$3.92M |
|
58
Dyne Therapeutics
DYN
$1.92B
| $10.6M | 0.25% |
1,014,611
-212,469
| -17% | -$2.22M |
|
59
Keros Therapeutics
KROS
$640M
| $10.4M | 0.25% |
1,018,734
| – | – |
|
|
SLRN
60
DELISTED
ACELYRIN
SLRN
| $9.88M | 0.24% |
4,001,711
| – | – |
|
61
Agios Pharmaceuticals
AGIO
$2.36B
| $9.54M | 0.23% |
325,500
+298,800
| +1,119% | +$8.75M |
|
62
AbCellera Biologics
ABCL
$1.19B
| $9.32M | 0.22% |
4,180,768
| – | – |
|
63
Adicet Bio
ACET
$60.8M
| $8.64M | 0.21% |
11,447,140
| – | – |
|
64
ADC Therapeutics
ADCT
$370M
| $8.42M | 0.2% |
5,968,451
| – | – |
|
65
Prelude Therapeutics
PRLD
$69.1M
| $8.38M | 0.2% |
10,909,256
| – | – |
|
66
Avalo Therapeutics
AVTX
$139M
| $7.75M | 0.18% |
967,000
| – | – |
|
|
WHWK
67
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $7.42M | 0.18% |
+4,166,000
| New | +$7.42M |
|
68
Akero Therapeutics
AKRO
$3.65B
| $7.28M | 0.17% |
179,900
+113,900
| +173% | +$4.61M |
|
69
PMV Pharmaceuticals
PMVP
$82.1M
| $7.06M | 0.17% |
6,475,291
| – | – |
|
70
Trevi Therapeutics
TRVI
$871M
| $7.04M | 0.17% |
+1,120,000
| New | +$7.04M |
|
|
KMTS
71
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$871M
| $6.23M | 0.15% |
+250,000
| New | +$6.23M |
|
72
Corbus Pharmaceuticals
CRBP
$121M
| $6.22M | 0.15% |
1,172,287
| – | – |
|
73
InspireMD
NSPR
$101M
| $5.74M | 0.14% |
2,133,405
| – | – |
|
74
Scholar Rock
SRRK
$3.3B
| $4.88M | 0.12% |
151,800
| – | – |
|
75
Forte Biosciences
FBRX
$138M
| $4.6M | 0.11% |
593,088
-6,912
| -1% | -$53.6K |
|